APGSEQ® - Clinical Metagenomic Sequencing
APG provides APGSEQ®, Taiwan FDA Laboratory Developed Tests-certified metagenomic Next Generation Sequencing (mNGS) service for clinical diagnosis of infectious diseases.
Feature of APGSEQ®：
Detect more than 19,000+ pathogens (including Bacteria, Fungi, Viruses, and Parasite)
Increase of 62% in detection rate compared to conventional microbiology tests.
Provide test results under 48-72 hrs.
The adventages allow the physician to adjust treatment in advance precisely, improving the quality of medical care for patients.